We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$31.7B
AUM Growth
+$4.48B
(+16%)
Cap. Flow
+$4.51B
Cap. Flow
% of AUM
14.22%
Top 10 Holdings %
Top 10 Hldgs %
32.81%
Holding
4,352
New
1,569
Increased
780
Reduced
748
Closed
1,248
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$677M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$537M |
| 3 |
Amazon
AMZN
|
+$322M |
| 4 |
Walmart Inc
WMT
|
+$265M |
| 5 |
Applied Materials
AMAT
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$859M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$513M |
| 3 |
Johnson & Johnson
JNJ
|
+$234M |
| 4 |
Amphenol
APH
|
+$216M |
| 5 |
Apple
AAPL
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.86% |
| 2 | Financials | 7.45% |
| 3 | Consumer Discretionary | 5.26% |
| 4 | Industrials | 5.05% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Akanda
AKAN
$2.77M
| $21K | ﹤0.01% |
+2,115
| New | +$68.3K |
|
2977
Inhibikase Therapeutics
IKT
$388M
| $21K | ﹤0.01% |
+10,570
| New | +$16.8K |
|
2978
SHF Holdings
SHFS
$1.13M
| $21K | ﹤0.01% |
+19,918
| New | +$49.7K |
|
2979
Dare Bioscience
DARE
$21M
| $20K | ﹤0.01% |
+10,497
| New | +$20.9K |
|
2980
Marker Therapeutics
MRKR
$18.7M
| $20K | ﹤0.01% |
+13,937
| New | +$15.8K |
|
2981
Xilio Therapeutics
XLO
$60.3M
| $20K | ﹤0.01% |
2,278
+511
| +29% | +$5.37K |
|
2982
Skye Bioscience
SKYE
$18.3M
| $20K | ﹤0.01% |
+27,348
| New | +$39.9K |
|
|
DEVS
2983
DELISTED
DevvStream Corp
DEVS
| $20K | ﹤0.01% |
+14,606
| New | +$26.9K |
|
|
SLAI
2984
DELISTED
SOLAI Ltd ADS
SLAI
| $19K | ﹤0.01% |
+4,243
| New | +$54.7K |
|
|
HYFT
2985
MindWalk Holdings
HYFT
$61.6M
| $19K | ﹤0.01% |
+10,771
| New | +$19K |
|
|
ADGM
2986
Adagio Medical Holdings
ADGM
$15.2M
| $19K | ﹤0.01% |
+18,618
| New | +$22.1K |
|
|
EDHL
2987
Everbright Digital
EDHL
$6.93M
| $19K | ﹤0.01% |
3,281
-6,567
| -67% | -$82.1K |
|
2988
CaliberCos
CWD
$4.6M
| $18K | ﹤0.01% |
+14,626
| New | +$39.2K |
|
2989
Fenbo Holdings
FEBO
$8.79M
| $18K | ﹤0.01% |
13,469
-1,564
| -10% | -$1.33K |
|
2990
MoneyHero
MNY
$40.6M
| $18K | ﹤0.01% |
14,316
-43,414
| -75% | -$56.9K |
|
2991
Outdoor Holding Co
POWW
$247M
| $18K | ﹤0.01% |
+11,071
| New | +$19K |
|
|
TSE
2992
DELISTED
Trinseo
TSE
| $18K | ﹤0.01% |
+37,379
| New | +$44.6K |
|
|
MEHA
2993
DELISTED
FUNCTIONAL BRANDS INC
MEHA
| $18K | ﹤0.01% |
+96,633
| New | +$44.2K |
|
|
CABR
2994
Caring Brands
CABR
$12.1M
| $18K | ﹤0.01% |
+21,667
| New | +$22.3K |
|
2995
Actinium Pharmaceuticals
ATNM
$25M
| $17K | ﹤0.01% |
+13,010
| New | +$19K |
|
|
EM
2996
DELISTED
Smart Share Global Ltd
EM
| $17K | ﹤0.01% |
+14,626
| New | +$19.5K |
|
2997
InspireMD
NSPR
$34.7M
| $17K | ﹤0.01% |
+10,089
| New | +$21K |
|
|
TEAD
2998
Teads Holding Co
TEAD
$67.7M
| $17K | ﹤0.01% |
+24,431
| New | +$25.9K |
|
2999
Stran & Co
SWAG
$36.5M
| $17K | ﹤0.01% |
10,760
-1,866
| -15% | -$3.65K |
|
3000
Metagenomi Therapeutics
MGX
$46.3M
| $17K | ﹤0.01% |
11,091
-3,006
| -21% | -$6.51K |
|
Similar funds
DB
HRT Financial's Q4 2025 Portfolio in Review
As of Q4 2025, HRT Financial held 4,352 positions worth $31.7B, up 16% from $27.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
HRT Financial deployed $4.51B of net new capital in Q4 2025, opening 1,569 new positions and adding to 780 existing holdings. Its largest new stake was Broadcom: 1,892,942 shares worth $655M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $859M trimmed.
- HRT Financial's largest Q4 2025 buy was Broadcom: 1,892,942 shares worth $655M.
- HRT Financial added most to iShares Russell 2000 ETF in Q4 2025, an estimated $537M increase.
- HRT Financial's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $859M.
- HRT Financial fully exited CRH in Q4 2025, selling an estimated $158M.
- HRT Financial's ten largest holdings make up 33% of its $31.7B portfolio in Q4 2025.
- HRT Financial opened 1,569 new positions and closed 1,248 in Q4 2025.
- HRT Financial's portfolio value rose 16% quarter-over-quarter to $31.7B.
Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.